{"name":"Synmosa Biopharma Corp.","slug":"synmosa-biopharma-corp","ticker":"","exchange":"","domain":"synmosa.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Goofice®","genericName":"Goofice®","slug":"goofice","indication":"Type 2 diabetes","status":"phase_3"}]}],"pipeline":[{"name":"Goofice®","genericName":"Goofice®","slug":"goofice","phase":"phase_3","mechanism":"Goofice is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNQWJJWkZMYVJVck4tOElDOTdyY1YxUDlrbzl1Q05yYURQeWNXV0FDUjZud0U2RjdYS0dMTW5fcWJCVTUyZ3ZCenQtQmtKcXQ0UXJYeFpGN0tWTFMwV1phOHZVbnV2eEdFaEE1QVRud3M1TEo4b0ctSHM2R2wzZzlmaEFVcHRPamhqNGRGNkZWTm5wcXlvMGpEbEI5SlVicFBZa3NCSnpZeDFWRjJH?oc=5","date":"2025-10-22","type":"pipeline","source":"全球醫療採購網","summary":"Synmosa Biopharma Launches Public Tender Offer for 15–30% Stake in Genovate Biotechnology with 30% Premium, Shaking Up Taiwan’s Established Pharma Sector｜Institute for Biotechnology and Medicine Indus","headline":"Synmosa Biopharma Launches Public Tender Offer for 15–30% Stake in Genovate Biotechnology with 30% Premium, Shaking Up T","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVEFVX3lxTE9hSFJrSGdZRmRtTTBQN19TSk1OTkYtWmJpc21uWmFXSmtQS2tkaTh4LV9tUktPNzY4dHpYaGMyMWRpNExsSGpFbDdJLTlrOXV6d3hfZg?oc=5","date":"2025-09-17","type":"pipeline","source":"Taiwan News","summary":"Taiwan's Synmosa Biopharma eyes up to 30% stake in Genovate Biotechnology - Taiwan News","headline":"Taiwan's Synmosa Biopharma eyes up to 30% stake in Genovate Biotechnology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxPZTN0X3RHS0JuNzQ2Y24yd25EdTlvN2tETWtWdlYtd1NMekdCOFZrcTNtZlFhRTcwSF9GWnR2SUktTWE3VmZKcnhHSWZfaG5qZE9TbUdDczV2bmZaeG9LMmRvc3pZV3VMeHhUaHJLcDlwSkRBS0g3NjN4ZWg2THJha1NZcjJjVURHM28yWUdSQk9zWlNCZEEwQkM1aHdiSm5JWUJZbkRLRFhJUjE0amlQdnpfZVBNaE9ROVUteVdkRUw5VUFzY2xCb3ZtamhCcUhOdjkw?oc=5","date":"2025-08-20","type":"pipeline","source":"Plataforma Media","summary":"How 102 Taiwanese Companies are Reshaping Taiwan's Workplaces with Tech, Trust, and Inclusion - Plataforma Media","headline":"How 102 Taiwanese Companies are Reshaping Taiwan's Workplaces with Tech, Trust, and Inclusion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQbExqVzgwdTNib0U0VjlybkNxV0hJSEluMUF5emd5WGp6d3RuTzRtR000X1VQTWh6VHpqMG5wdnhkWk9NMHRkX1Z3WjJhTHFFcWNPWkpQNGFGNThyY3FYYW5uTUszSE1jOFVPaDI0YWVweDdHaW1GMVJJUm9ucl91RmVpRmRlLVJZWm5hNFJROA?oc=5","date":"2025-08-19","type":"deal","source":"Air Cargo Week","summary":"KLN Pharma appointed as 4PL partner for Synmosa in Hong Kong - Air Cargo Week","headline":"KLN Pharma appointed as 4PL partner for Synmosa in Hong Kong","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNZXU1Y0phNzg4LXltaTV6QWQ4ZnMtajRBQ0k1SFZRYnJrUWw5LXNNenlUUWRXSVRmelZuNnRqcGtYdjZmU3VieVl0aUtmZVlUSWNSRGEzUXdjUm9IcWNiMkJxTExfZWM2VlhoV3MyMGYxai1KdEg4OUUxX3FqVEl6VF94blU2eF9mZXN0N3NVd3hDcmc?oc=5","date":"2023-01-12","type":"earnings","source":"全球醫療採購網","summary":"Taiwan business watch 2022: Biomedical sector top 20 by revenue and segment - 全球醫療採購網","headline":"Taiwan business watch 2022: Biomedical sector top 20 by revenue and segment - 全球醫療採購網","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTFB6NnFncWVzeXpOMkV0XzNlWEtXdm9MM1ZkSWxzeU9hdGI4OVZkY291d0JoLS1yWGdxMXV6RVlZQW80bXNhSFV3MUhqRWxyVG1iOG84ejdqQXJkT3UxejlNWDc3SHlvTEpwWTQxQmkxVlpCSTFRUlRVX2h3?oc=5","date":"2019-02-17","type":"pipeline","source":"Taipei Times","summary":"Blood pressure medicines recalled due to impurities - Taipei Times","headline":"Blood pressure medicines recalled due to impurities","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTFBvYkRJYzhwT25fQW9GU1FzUU1fSHFfTFZuWm9sSXVCSjZRd0RSRk51VWMzMU5BRUhRdjVKamlwdldnM3ZaSzJxcFg4UzR1VldvR3JkV1ZHSQ?oc=5","date":"2017-09-08","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Orient EuroPharma Co., Ltd. (4120.TWO) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Orient EuroPharma Co., Ltd. (4120.TWO) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTE1FYVFwakVCQXBlZURwVDBWTlBUQjNDYVozZHA3MmNGSWxfTXdkRnRWNXhFZFZOb3BzSGpScXE2Qk5qb0Y2X3EtWmZ6a3BsWUxwYjRrVzM5cw?oc=5","date":"2017-05-19","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Synmosa Biopharma Corporation (4114.TWO) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Synmosa Biopharma Corporation (4114.TWO) stock price, news, quote and history","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}